Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

Literature DB >> 5316908

Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

M S Artenstein, W C Branche, J G Zimmerly, R L Cohen, E C Tramont, D L Kasper, C Harkins.

Abstract

Studies with 4 lots of group A meningococcal polysaccharides in 458 adult human volunteers showed that such vaccines are nontoxic and highly immunogenic. Comparisons of jet injection and subcutaneous (needle) methods of administration showed that both were equally immunogenic.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1971 PMID： 5316908 PMCID： PMC2427932

Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408

7 in total

1. Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

Authors: M S Artenstein; R Gold; J G Zimmerly; F A Wyle; W C Branche; C Harkins
Journal: J Infect Dis Date: 1970-04 Impact factor: 5.226

2. Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors: M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal: N Engl J Med Date: 1970-02-19 Impact factor: 91.245

3. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.

Authors: R Gold; M S Artenstein
Journal: Bull World Health Organ Date: 1971 Impact factor: 9.408

4. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors: E C Gotschlich; I Goldschneider; M S Artenstein
Journal: J Exp Med Date: 1969-06-01 Impact factor: 14.307

5. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors: E C Gotschlich; T Y Liu; M S Artenstein
Journal: J Exp Med Date: 1969-06-01 Impact factor: 14.307

6. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

Authors: E C Gotschlich; I Goldschneider; M S Artenstein
Journal: J Exp Med Date: 1969-06-01 Impact factor: 14.307

7. Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors: I Goldschneider; E C Gotschlich; M S Artenstein
Journal: J Exp Med Date: 1969-06-01 Impact factor: 14.307

7 in total

4 in total

Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

1. Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

2. Prevention of meningococcal disease by group C polysaccharide vaccine.

3. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.

4. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

5. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

6. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

7. Human immunity to the meningococcus. I. The role of humoral antibodies.

Review 1. Diagnosis and management of bacterial meningitis.

2. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.

3. Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

4. Antibody responses to meningococcal polysaccharide vaccines.